{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:14:30Z","timestamp":1790612070241,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.exer.2022.109186","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T01:54:43Z","timestamp":1657331683000},"page":"109186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["NADH-Cytochrome B5 reductase 2 suppresses retinal vascular dysfunction through regulation of vascular endothelial growth factor A in diabetic retinopathy"],"prefix":"10.1016","volume":"222","author":[{"given":"Jun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2022.109186_bib1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.exer.2022.109186_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5356","article-title":"Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy","volume":"369","author":"Binet","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.exer.2022.109186_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100921","article-title":"Sustained suppression of VEGF for treatment of retinal\/choroidal vascular diseases","volume":"83","author":"Campochiaro","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2022.109186_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cmet.2021.01.011","article-title":"Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition","volume":"33","author":"Crespo-Garcia","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.exer.2022.109186_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/pcan.2013.21","article-title":"Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia","volume":"16","author":"Devaney","year":"2013","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.exer.2022.109186_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/biology9110347","article-title":"Differential effects of empagliflozin on microvascular complications in murine models of type 1 and type 2 diabetes","volume":"9","author":"Eid","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.exer.2022.109186_bib7","doi-asserted-by":"crossref","first-page":"E005","DOI":"10.1017\/S0952523820000048","article-title":"Of neurons and pericytes: the neuro-vascular approach to diabetic retinopathy","volume":"37","author":"Eleftheriou","year":"2020","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.exer.2022.109186_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vph.2014.04.007","article-title":"Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism","volume":"62","author":"Gong","year":"2014","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.exer.2022.109186_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105871","article-title":"Dihydroartemisinin ameliorates retinal vascular dysfunction in diabetes mellitus via the FASN\/Kmal-mTOR\/SREBP1 feedback loop","volume":"174","author":"Gu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2022.109186_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00125-017-4435-8","article-title":"Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond","volume":"61","author":"Hammes","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2022.109186_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00418338","article-title":"Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids","volume":"39","author":"Hammes","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2022.109186_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/1440-1681.13163","article-title":"MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1\u03b1","volume":"47","author":"Han","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.exer.2022.109186_bib13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.kint.2019.02.042","article-title":"Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence","volume":"96","author":"Hanna","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.exer.2022.109186_bib14","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/biom10111583","article-title":"Effects of diabetes on microcirculation and leukostasis in retinal and non-ocular tissues: implications for diabetic retinopathy","volume":"10","author":"Herdade","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.exer.2022.109186_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biopha.2018.02.110","article-title":"Gefitinib inhibits retina angiogenesis by affecting VEGF signaling pathway","volume":"102","author":"Hu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exer.2022.109186_bib16","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.3390\/ijms22115928","article-title":"Opa1 deficiency promotes development of retinal vascular lesions in diabetic retinopathy","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2022.109186_bib17","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1167\/iovs.17-21416","article-title":"Apatinib, an inhibitor of vascular endothelial growth factor receptor 2, suppresses pathologic ocular neovascularization in mice","volume":"58","author":"Kim","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2022.109186_bib18","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1161\/CIRCRESAHA.117.311066","article-title":"TPL2 (Therapeutic targeting tumor progression locus-2)\/ATF4 (activating transcription factor-4)\/SDF1\u03b1 (chemokine stromal cell-derived factor-\u03b1) axis suppresses diabetic retinopathy","volume":"121","author":"Lai","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2022.109186_bib19","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/dc15-2171","article-title":"Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010","volume":"39","author":"Leasher","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2022.109186_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104924","article-title":"Hypoxia-inducible factor-1\u03b1: a promising therapeutic target for vasculopathy in diabetic retinopathy","volume":"159","author":"Li","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2022.109186_bib21","first-page":"9161","article-title":"Survivin contributes to the progression of diabetic retinopathy through HIF-1\u03b1 pathway","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.exer.2022.109186_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4875421","article-title":"Scutellarin prevents angiogenesis in diabetic retinopathy by downregulating VEGF\/ERK\/FAK\/Src pathway signaling","author":"Long","year":"2019","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.exer.2022.109186_bib23","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1038\/npjamd.2016.6","article-title":"Cytochrome b(5) reductase and the control of lipid metabolism and healthspan","volume":"2","author":"Martin-Montalvo","year":"2016","journal-title":"NPJ. Aging. Mech. Dis."},{"key":"10.1016\/j.exer.2022.109186_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106698","article-title":"Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis","volume":"130","author":"Mei","year":"2020","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.exer.2022.109186_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s40880-015-0044-4","article-title":"Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis","volume":"34","author":"Ming","year":"2015","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.exer.2022.109186_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbadis.2013.11.011","article-title":"Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells","volume":"1842","author":"Nahomi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.exer.2022.109186_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/HYPERTENSIONAHA.117.10271","article-title":"Mechanisms of VEGF (Vascular endothelial growth factor) inhibitor-associated hypertension and vascular disease","volume":"71","author":"Pandey","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.exer.2022.109186_bib28","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/db20-1268","article-title":"Tribbles homolog 3 mediates the development and progression of diabetic retinopathy","volume":"70","author":"Pitale","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2022.109186_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/CIRCRESAHA.117.310705","article-title":"Cytochrome b5 reductase 3 modulates soluble guanylate cyclase redox state and cGMP signaling","volume":"121","author":"Rahaman","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2022.109186_bib30","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCULATIONAHA.117.029004","article-title":"Circular noncoding RNA HIPK3 mediates retinal vascular dysfunction in diabetes mellitus","volume":"136","author":"Shan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2022.109186_bib31","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1089\/ars.2013.5479","article-title":"Membrane-bound CYB5R3 is a common effector of nutritional and oxidative stress response through FOXO3a and Nrf2","volume":"21","author":"Siendones","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.exer.2022.109186_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2022.109186_bib33","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCRESAHA.119.315886","article-title":"Endothelium-targeted deletion of microRNA-15a\/16-1 promotes poststroke angiogenesis and improves long-term neurological recovery","volume":"126","author":"Sun","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2022.109186_bib34","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1001\/jama.2020.22829","article-title":"Anti-VEGF therapy or vitrectomy surgery for vitreous hemorrhage from proliferative diabetic retinopathy","volume":"324","author":"Tan","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.exer.2022.109186_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2407-7-55","article-title":"Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis","volume":"7","author":"Turashvili","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exer.2022.109186_bib36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American academy of ophthalmology","volume":"124","author":"VanderVeen","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2022.109186_bib37","doi-asserted-by":"crossref","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","article-title":"Diabetic retinopathy","volume":"2","author":"Wong","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.exer.2022.109186_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21121756","article-title":"Inhibition of hypoxia-induced retinal angiogenesis by specnuezhenide, an effective constituent of ligustrum lucidum ait., through suppression of the HIF-1\u03b1\/VEGF signaling pathway","volume":"21","author":"Wu","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.exer.2022.109186_bib39","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1007\/s13277-013-1497-1","article-title":"Cytochrome b5 reductase 2 is a novelcandidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma","volume":"35","author":"Xiao","year":"2014","journal-title":"Tumour. Biol."},{"key":"10.1016\/j.exer.2022.109186_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00125-020-05299-x","article-title":"Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src\/Akt\/cofilin signalling in experimental diabetic retinopathy","volume":"64","author":"Xie","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2022.109186_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.molmed.2010.07.003","article-title":"The Norrin\/Frizzled4 signaling pathway in retinal vascular evelopment and disease","volume":"16","author":"Ye","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.exer.2022.109186_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194755","article-title":"Proteomic biomarkers of retinal inflammation in diabetic retinopathy","volume":"20","author":"Youngblood","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2022.109186_bib43","doi-asserted-by":"crossref","first-page":"11666","DOI":"10.1038\/s41598-019-48053-z","article-title":"Endothelial RhoA GTPase is essential for in vitro endothelial functions but dispensable for physiological in vivo angiogenesis","volume":"9","author":"Zahra","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2022.109186_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ebiom.2019.10.004","article-title":"Downregulation of circRNA DMNT3B contributes to diabetic retinal vascular dysfunction through targeting miR-20b-5p and BAMBI","volume":"49","author":"Zhu","year":"2019","journal-title":"EBioMedicine"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483522002664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483522002664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:19:53Z","timestamp":1757999993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483522002664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"alternative-id":["S0014483522002664"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2022.109186","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NADH-Cytochrome B5 reductase 2 suppresses retinal vascular dysfunction through regulation of vascular endothelial growth factor A in diabetic retinopathy","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2022.109186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109186"}}